Putting this together with our laboratory data, the compartmental responses to the BTKi and BCL2i can now be explained by the different proliferative capacities of the CLL subpopulations residing in these different anatomical compartments. The gene discussed is IBTK; the disease is B-cell chronic lymphocytic leukemia.